Janus Henderson Group
OVID icon

Janus Henderson Group’s Ovid Therapeutics OVID Stock Holding History

Janus Henderson Group’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.7M Buy
+10,714,000
New +$19.2M 0.01% 572

Other funds holding OVID

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Janus Henderson Group's OVID Position: Q1 2026 in Review

Janus Henderson Group opened a new position in Ovid Therapeutics (OVID) in Q1 2026: 10,714,000 shares worth $23.7M. The stake represents 0.01% of the portfolio and ranks #572 among its holdings.

103 funds tracked by Wall St. Rank hold OVID as of Q1 2026.

  • Janus Henderson Group held 10,714,000 shares of Ovid Therapeutics worth $23.7M as of Q1 2026.
  • Ovid Therapeutics was a new Janus Henderson Group position in Q1 2026.
  • Ovid Therapeutics made up 0.01% of Janus Henderson Group's portfolio in Q1 2026, its #572 holding.
  • 103 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.